BioCentury
ARTICLE | Clinical News

Hy-Gene Inc. regulatory update

June 27, 1994 7:00 AM UTC

The Ventura, Calif., company received U.S. Patent No. 5,292,655 covering a method to formulate a histologically complete human skin substitute. The method permits the production of as much as four squ...